INTERLEUKIN GENETICS INC: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $2.5M
- Net Income/Loss (FY2016)
- -$7.4M
- Total Assets (FY2016)
- $3.8M
- Total Equity (FY2016)
- -$2.8M
- Cash Flows from Operating Activities (FY2016)
- -$6.5M
Source: INTERLEUKIN GENETICS INC 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
